Zhangzhou Pientzehuang Pharmaceutical Co Ltd Total Liabilities
Zhangzhou Pientzehuang Pharmaceutical Co Ltd total liabilities. Based on the latest financial reports, Zhangzhou Pientzehuang Pharmaceutical Co Ltd (600436) has total liabilities worth CN¥2.63 Billion CNY (≈ $384.61 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 600436 asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Zhangzhou Pientzehuang Pharmaceutical Co Ltd (2000–2025)
Total liabilities of Zhangzhou Pientzehuang Pharmaceutical Co Ltd from 2000 to 2025. This chart illustrates how Zhangzhou Pientzehuang Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore 600436 long-term investment intensity to see how much of total assets are deployed in long-term investments.
Zhangzhou Pientzehuang Pharmaceutical Co Ltd Competitors by Total Liabilities
The table below lists competitors of Zhangzhou Pientzehuang Pharmaceutical Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Zhejiang Nhu Co Ltd
SHE:002001
|
China | CN¥12.17 Billion |
|
MAPFRE S.A.ADR 2 / EO-10
F:CMA
|
Germany | €50.49 Billion |
|
Lululemon Athletica Inc.
NASDAQ:LULU
|
USA | $3.71 Billion |
|
CNPC Capital Co Ltd
SHE:000617
|
China | CN¥956.92 Billion |
|
Invesco Plc
NYSE:IVZ
|
USA | $13.57 Billion |
|
Embraer SA ADR
NYSE:ERJ
|
USA | $8.59 Billion |
|
China International Capital Corp Ltd
SHG:601995
|
China | CN¥665.02 Billion |
Liability Composition Analysis (2000–2025)
This chart breaks down Zhangzhou Pientzehuang Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see 600436 current and non-current assets.
Liquidity & Leverage Metrics
Zhangzhou Pientzehuang Pharmaceutical Co Ltd Total Liabilities Ratios Explained
Zhangzhou Pientzehuang Pharmaceutical Co Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 5.02 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.17 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.14 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Zhangzhou Pientzehuang Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Zhangzhou Pientzehuang Pharmaceutical Co Ltd (2000–2025)
The table below shows the annual total liabilities of Zhangzhou Pientzehuang Pharmaceutical Co Ltd from 2000 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥2.47 Billion ≈ $361.73 Million |
-8.48% |
| 2024-12-31 | CN¥2.70 Billion ≈ $395.23 Million |
-14.53% |
| 2023-12-31 | CN¥3.16 Billion ≈ $462.40 Million |
+13.67% |
| 2022-12-31 | CN¥2.78 Billion ≈ $406.79 Million |
+17.86% |
| 2021-12-31 | CN¥2.36 Billion ≈ $345.14 Million |
+21.01% |
| 2020-12-31 | CN¥1.95 Billion ≈ $285.20 Million |
+5.86% |
| 2019-12-31 | CN¥1.84 Billion ≈ $269.40 Million |
+36.36% |
| 2018-12-31 | CN¥1.35 Billion ≈ $197.57 Million |
+10.39% |
| 2017-12-31 | CN¥1.22 Billion ≈ $178.97 Million |
-4.97% |
| 2016-12-31 | CN¥1.29 Billion ≈ $188.34 Million |
+71.24% |
| 2015-12-31 | CN¥751.60 Million ≈ $109.98 Million |
+13.48% |
| 2014-12-31 | CN¥662.34 Million ≈ $96.92 Million |
-0.71% |
| 2013-12-31 | CN¥667.05 Million ≈ $97.61 Million |
-1.21% |
| 2012-12-31 | CN¥675.22 Million ≈ $98.81 Million |
+77.83% |
| 2011-12-31 | CN¥379.69 Million ≈ $55.56 Million |
+4.61% |
| 2010-12-31 | CN¥362.97 Million ≈ $53.11 Million |
-15.07% |
| 2009-12-31 | CN¥427.35 Million ≈ $62.54 Million |
+34.20% |
| 2008-12-31 | CN¥318.45 Million ≈ $46.60 Million |
+50.19% |
| 2007-12-31 | CN¥212.03 Million ≈ $31.03 Million |
+93.59% |
| 2006-12-31 | CN¥109.53 Million ≈ $16.03 Million |
+28.01% |
| 2005-12-31 | CN¥85.56 Million ≈ $12.52 Million |
+334.47% |
| 2004-12-31 | CN¥19.69 Million ≈ $2.88 Million |
-52.44% |
| 2003-12-31 | CN¥41.40 Million ≈ $6.06 Million |
-75.79% |
| 2002-12-31 | CN¥170.99 Million ≈ $25.02 Million |
+37.51% |
| 2001-12-31 | CN¥124.34 Million ≈ $18.20 Million |
+5.98% |
| 2000-12-31 | CN¥117.33 Million ≈ $17.17 Million |
-- |
About Zhangzhou Pientzehuang Pharmaceutical Co Ltd
Zhangzhou Pientzehuang Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and distributes pharmaceuticals and cosmetics in China and internationally. The company offers traditional Chinese medicines and health products in various forms, including capsule, ointment, tablet, syrup, and pill; health care food and functional drinks; special efficacy cosmetics; and household chemic… Read more